Venetoclax–Rituximab and Emerging Treatment Strategies After c-BTKi Exposure in Relapsed/Refractory CLL: A Real-World Cohort and Literature Overview. - Dimou, Maria; Fioretzaki, Rodanthi; Zerzi, Calliope; Konstantinou, Eliana; Asimakopoulos, John V.; Arapaki, Maria; Piperidou, Alexia; Machairas, Alexandros; Kopsaftopoulou, Anastasia; Liaskas, Athanasios; Bitsani, Aikaterini; Belia, Marina; et al. (Cancers, 2025)